CITIGROUP INC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$2,615,836
+6.8%
145,729
+20.8%
0.00%0.0%
Q2 2023$2,450,321
-61.8%
120,646
-65.7%
0.00%
-60.0%
Q1 2023$6,419,312
+86.2%
351,936
+111.1%
0.01%
+150.0%
Q4 2022$3,446,963
-51.3%
166,681
-38.4%
0.00%
-50.0%
Q3 2022$7,081,000
+51.6%
270,683
+46.9%
0.00%
+33.3%
Q2 2022$4,670,000
+210.7%
184,300
+287.2%
0.00%
+200.0%
Q1 2022$1,503,000
-65.9%
47,604
-56.3%
0.00%
-50.0%
Q4 2021$4,407,000
+11.9%
108,900
-3.6%
0.00%0.0%
Q3 2021$3,940,000
-12.1%
112,985
-30.8%
0.00%
-33.3%
Q2 2021$4,483,000
+36.0%
163,269
+39.1%
0.00%
+50.0%
Q1 2021$3,296,000
+439.4%
117,396
+399.2%
0.00%
Q4 2020$611,000
+373.6%
23,518
+211.7%
0.00%
Q3 2020$129,000
-80.3%
7,546
-71.4%
0.00%
-100.0%
Q2 2020$654,000
+391.7%
26,421
+175.0%
0.00%
Q1 2020$133,000
+37.1%
9,609
+0.3%
0.00%
Q4 2019$97,000
+44.8%
9,585
+30.3%
0.00%
Q3 2019$67,000
-23.9%
7,354
-33.4%
0.00%
Q2 2019$88,000
-37.6%
11,043
-2.1%
0.00%
Q1 2019$141,000
+15.6%
11,275
-1.1%
0.00%
Q4 2018$122,000
+56.4%
11,395
+104.5%
0.00%
Q3 2018$78,000
+66.0%
5,571
+46.1%
0.00%
Q2 2018$47,000
+2.2%
3,814
+27.1%
0.00%
Q1 2018$46,0003,0000.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders